Free Trial

Ardent Health Partners, LLC (NYSE:ARDT) Receives $21.82 Average Price Target from Brokerages

Ardent Health Partners logo with Medical background

Shares of Ardent Health Partners, LLC (NYSE:ARDT - Get Free Report) have received an average rating of "Buy" from the twelve analysts that are currently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $21.82.

Several equities research analysts have recently issued reports on ARDT shares. Loop Capital assumed coverage on shares of Ardent Health Partners in a report on Monday, August 12th. They issued a "buy" rating and a $18.00 target price for the company. Bank of America downgraded Ardent Health Partners from a "buy" rating to a "neutral" rating and reduced their price target for the stock from $22.00 to $19.00 in a report on Wednesday, November 6th. Morgan Stanley initiated coverage on Ardent Health Partners in a report on Monday, August 12th. They set an "overweight" rating and a $27.00 price objective for the company. Truist Financial initiated coverage on Ardent Health Partners in a research note on Monday, August 12th. They issued a "buy" rating and a $21.00 target price on the stock. Finally, Leerink Partnrs upgraded shares of Ardent Health Partners to a "strong-buy" rating in a report on Monday, August 12th.

Read Our Latest Stock Analysis on ARDT

Ardent Health Partners Stock Performance

NYSE:ARDT traded down $0.19 during midday trading on Wednesday, hitting $16.45. 180,749 shares of the company traded hands, compared to its average volume of 367,102. The firm has a fifty day moving average price of $18.13. Ardent Health Partners has a 12-month low of $14.57 and a 12-month high of $20.72. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91.

Institutional Trading of Ardent Health Partners

A number of hedge funds and other institutional investors have recently bought and sold shares of ARDT. Wellington Management Group LLP acquired a new stake in Ardent Health Partners during the 3rd quarter worth approximately $28,724,000. Point72 Asset Management L.P. acquired a new stake in Ardent Health Partners in the third quarter valued at $27,428,000. Goldentree Asset Management LP acquired a new position in Ardent Health Partners during the third quarter worth about $22,897,000. Allspring Global Investments Holdings LLC purchased a new position in shares of Ardent Health Partners during the third quarter valued at approximately $13,119,000. Finally, Soros Fund Management LLC acquired a new position in shares of Ardent Health Partners in the 3rd quarter valued at $4,595,000.

Ardent Health Partners Company Profile

(Get Free Report

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

Recommended Stories

Analyst Recommendations for Ardent Health Partners (NYSE:ARDT)

Should you invest $1,000 in Ardent Health Partners right now?

Before you consider Ardent Health Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.

While Ardent Health Partners currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines